TMO Stock Overview
Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Thermo Fisher Scientific Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$536.29 |
| 52 Week High | US$603.82 |
| 52 Week Low | US$415.60 |
| Beta | 0.77 |
| 11 Month Change | -7.71% |
| 3 Month Change | -8.98% |
| 1 Year Change | 3.76% |
| 33 Year Change | 4.20% |
| 5 Year Change | 85.68% |
| Change since IPO | 16,987.21% |
Recent News & Updates
Recent updates
Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?
Jun 18
Low Yield, High Growth: Unveiling The Power Of Thermo Fisher's Dividends
Jun 07Thermo Fisher: Renewed Growth Yet To Materialize, But Already Priced In (Rating Downgrade)
Apr 30Thermo Fisher Scientific Inc. (NYSE:TMO) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Apr 27Why Thermo Fisher Scientific Inc. (NYSE:TMO) Could Be Worth Watching
Apr 24Thermo Fisher Scientific: Too Hot To Handle
Apr 15Investors Still Waiting For A Pull Back In Thermo Fisher Scientific Inc. (NYSE:TMO)
Apr 02We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt
Mar 12Thermo Fisher's Bright Future Makes It A Great Buy On Weakness
Feb 06Here's What Analysts Are Forecasting For Thermo Fisher Scientific Inc. (NYSE:TMO) After Its Yearly Results
Feb 02Thermo Fisher: Blue Chip Stock Melded With Growth Characteristics
Jan 16Thermo Fisher: Downturn In Pharma And Biotech And Weak China Growth; Initiate With 'Hold'
Jan 06Is Now An Opportune Moment To Examine Thermo Fisher Scientific Inc. (NYSE:TMO)?
Dec 29Does Thermo Fisher Scientific (NYSE:TMO) Have A Healthy Balance Sheet?
Dec 11Thermo Fisher Scientific: I Am Still Waiting For An Attractive Buying Opportunity.
Dec 02Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Could Be 25% Below Their Intrinsic Value Estimate
Nov 07My Family Is Buying A Lot More Thermo Fisher Stock
Oct 31Thermo Fisher: An Up To 35% Undervalued Healthcare Gem I Like On Weakness
Sep 28Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?
Sep 10Thermo Fisher Scientific: A High-Quality Investment For Double-Digit Returns
Aug 28Thermo Fisher: Cash Flow Returns On Investments Analysis
Aug 14Calculating The Fair Value Of Thermo Fisher Scientific Inc. (NYSE:TMO)
Jul 25Shareholder Returns
| TMO | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | -1.0% | -0.6% | 1.8% |
| 1Y | 3.8% | -3.2% | 23.7% |
Return vs Industry: TMO exceeded the US Life Sciences industry which returned -3.2% over the past year.
Return vs Market: TMO underperformed the US Market which returned 23.7% over the past year.
Price Volatility
| TMO volatility | |
|---|---|
| TMO Average Weekly Movement | 2.6% |
| Life Sciences Industry Average Movement | 7.0% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 14.7% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: TMO has not had significant price volatility in the past 3 months.
Volatility Over Time: TMO's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1956 | 122,000 | Marc Casper | www.thermofisher.com |
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.
Thermo Fisher Scientific Inc. Fundamentals Summary
| TMO fundamental statistics | |
|---|---|
| Market cap | US$206.16b |
| Earnings (TTM) | US$6.03b |
| Revenue (TTM) | US$42.49b |
33.9x
P/E Ratio4.8x
P/S RatioIs TMO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TMO income statement (TTM) | |
|---|---|
| Revenue | US$42.49b |
| Cost of Revenue | US$25.34b |
| Gross Profit | US$17.15b |
| Other Expenses | US$11.12b |
| Earnings | US$6.03b |
Last Reported Earnings
Mar 30, 2024
Next Earnings Date
Jul 24, 2024
| Earnings per share (EPS) | 15.81 |
| Gross Margin | 40.37% |
| Net Profit Margin | 14.20% |
| Debt/Equity Ratio | 77.7% |
How did TMO perform over the long term?
See historical performance and comparison